Instrument Inactif

Autres langues Zogenix, Inc. Nasdaq

Actions

US98978L1052

Produits pharmaceutiques

Autres langues

08/06/23	Pulmocide Announces Expansion of Management Team
08/09/22	Oncolytics Biotech Appoints Jonathan Rigby to its Board of Directors
27/06/22	UCB updates financial guidance for 2022 while maintaining 2025 financial guidance
29/03/22	Zogenix Inc. - FINTEPLA (fenfluramine) Oral Solution Now FDA Approved for Treatment of Seizures Associated with Lennox-Gastaut Syndrome (LGS)
28/03/22	Degroof Petercam verhoogt koersdoel UCB
28/03/22	groen licht Fintepla goed nieuws voor UCB
28/03/22	U.S. FDA approves UCB's drug for rare childhood epilepsy
23/03/22	UBS haalt UCB van verkooplijst
21/03/22	Kepler Cheuvreux verhoogt koersdoel UCB aanzienlijk
08/03/22	Bel20 weet herstel net vast te houden
08/03/22	Bel20 herstelt
08/03/22	Bel20 herstelt
08/03/22	Brussel vrijwel onveranderd van start
07/03/22	Zogenix Completes $1.9 Billion Buyout by UCB; Shares Delisted From Nasdaq
07/03/22	UCB Closes Zogenix Acquisition for Nearly $1.9 Billion
07/03/22	UCB rondt overname Zogenix af
07/03/22	UCB Completes Acquisition of Zogenix, Inc.
07/03/22	ZOGENIX, INC. : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)
07/03/22	Zogenix To Present New Long-term Data on FINTEPLA (fenfluramine) in Lennox-Gastaut Syndrome (LGS) at AAN 2022
07/03/22	Zogenix : Amendment to Annual Report (Form 10-K/A)
07/03/22	Zogenix, Inc.(NasdaqGM:ZGNX) dropped from NASDAQ Composite Index
07/03/22	Zogenix, Inc.(NasdaqGM:ZGNX) dropped from S&P Pharmaceuticals Select Industry Index
07/03/22	Zogenix, Inc.(NasdaqGM:ZGNX) dropped from S&P TMI Index
07/03/22	Zogenix, Inc.(NasdaqGM:ZGNX) dropped from S&P Global BMI Index
04/03/22	Zogenix To Present New Long-term Data on FINTEPLA® (fenfluramine) in Lennox-Gastaut Syndrome (LGS) at AAN 2022